SLN
Silence Therapeutics PLC
NASDAQ: SLN · HEALTHCARE · BIOTECHNOLOGY
$7.31
+2.81% today
Updated 2026-04-30
Market cap
$363.70M
P/E ratio
—
P/S ratio
650.63x
EPS (TTM)
$-1.89
Dividend yield
—
52W range
$4 – $8
Volume
0.4M
Silence Therapeutics PLC (SLN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-4.03M | $-3.83M | $-6.98M | $-4.65M | $-10.55M | $-5.11M | $-4.88M | $-6.76M | $-9.46M | $-8.26M | $-10.07M | $-9.60M | $-16.76M | $1.73M | $-10.78M | $9.19M | $-57.04M | $-39.35M | $-67.64M | $-46.32M |
| Capital expenditures | $129000.00 | $531000.00 | $272000.00 | $225000.00 | $292000.00 | $275000.00 | $202000.00 | $138000.00 | $338000.00 | $850000.00 | $537000.00 | $173000.00 | $188000.00 | $9000.00 | $514000.00 | $1.80M | $545000.00 | $45000.00 | $211000.00 | $55000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $491000.00 | $1.22M | $544000.00 | $662000.00 | $659000.00 | $121000.00 | $656000.00 | $1.59M | $1.13M | $777000.00 | $475000.00 | $638000.00 | $681000.00 | $584000.00 | $4.39M | $11.65M | $12.69M | $13.05M | $13.03M | $8.07M |
| Free cash flow | $-4.16M | $-4.36M | $-7.25M | $-4.87M | $-10.84M | $-5.38M | $-5.08M | $-6.89M | $-9.80M | $-9.11M | $-10.60M | $-9.77M | $-16.95M | $1.72M | $-11.29M | $7.39M | $-57.59M | $-39.40M | $-67.85M | $-46.38M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |